jbs-01k

JSON twin: https://www.healthaidb.com/software/jbs-01k.json

Company Name

JLK

Product URL

https://healthairegister.com/radiology/products/jlk-inc-jbs-01k

Company URL

https://jlkgroup.com

Categories

Summary

JBS-01K is an AI-based medical imaging software that detects ischemic stroke lesions on brain MRI and classifies ischemic stroke subtype using imaging plus clinical AF data.

Description

Commercial AI medical device from JLK (JLK Inspection/Group) that performs automated DWI infarct detection/segmentation on MRI, provides ischemic stroke (TOAST-like) subtype classification using MRI and atrial fibrillation information, and is marketed for diagnostic support in acute stroke care. Cleared/approved by South Korea MFDS and has obtained CE certification; used in hospitals and reported in comparative validation studies versus other DWI tools.

Api Available

unknown

Certifications

Company Founding

2014

Company Offices

Compliance

Customers

Data Residency

Data Standards

Deployment Model

Features

Id

P2085

Integration Partners

Integrations

Languages Supported

Last Updated

2025-09-07

License

commercial proprietary

Links

Market Segment

Optional Modules

Os Platforms

Pricing Details

Reported non-reimbursed per-use price ~53,000 KRW (public media); commercial licensing and deployment fees — contact vendor for current pricing and trial options.

Pricing Model

enterprise_quote

Privacy Features

Ratings

Regions Available

Release Year

2019

Security Features

Specialties

Support Channels

System Requirements

DICOM-compatible image input; runs cloud, hybrid, or on dedicated local hardware

Target Users

Training Options

Type

product

User Reviews

Version

1.0

Canonical JSON

{
  "company_name": "JLK",
  "company_url": "https://jlkgroup.com",
  "company_offices": [
    "South Korea",
    "United States",
    "Japan"
  ],
  "company_founding": "2014",
  "product_url": "https://healthairegister.com/radiology/products/jlk-inc-jbs-01k",
  "categories": [
    "clinical",
    "diagnostic",
    "radiology",
    "neuro",
    "medical imaging",
    "AI-assisted diagnosis"
  ],
  "market_segment": [
    "enterprise",
    "hospital"
  ],
  "links": [
    "https://jlkgroup.com/en/about/",
    "https://healthairegister.com/radiology/products/jlk-inc-jbs-01k",
    "https://jlkgroup.com/static/pdf/en/JBS-01K_eng.pdf",
    "https://www.prnewswire.com/news-releases/ce-certification-for-ai-based-medical-solutions-of-jlk-inspection-ai-based-brain-image-analysis-jbs-01k-and-ai-based-prostate-image-analysis-jpc-01k-solutions-300858180.html",
    "https://www.nsmedicaldevices.com/news/jlk-inspection-ai-based/",
    "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7650084/",
    "https://www.kedglobal.com/bio-pharma/newsView/ked202401100015",
    "https://www.marketscreener.com/quote/stock/JLK-INC-120976148/news/JLK-Inspection-Announces-Its-Ischemic-Stroke-Diagnosis-Supporting-Software-JBS-01K-34586632/"
  ],
  "summary": "JBS-01K is an AI-based medical imaging software that detects ischemic stroke lesions on brain MRI and classifies ischemic stroke subtype using imaging plus clinical AF data.",
  "description": "Commercial AI medical device from JLK (JLK Inspection/Group) that performs automated DWI infarct detection/segmentation on MRI, provides ischemic stroke (TOAST-like) subtype classification using MRI and atrial fibrillation information, and is marketed for diagnostic support in acute stroke care. Cleared/approved by South Korea MFDS and has obtained CE certification; used in hospitals and reported in comparative validation studies versus other DWI tools.",
  "target_users": [
    "radiologists",
    "neuroradiologists",
    "neurologists",
    "stroke teams",
    "radiology technologists",
    "hospital administrators"
  ],
  "specialties": [
    "neurology",
    "neuroradiology",
    "stroke"
  ],
  "regions_available": [
    "South Korea",
    "European Union (CE-marked)",
    "Philippines"
  ],
  "languages_supported": [
    "Korean",
    "English"
  ],
  "pricing_model": "enterprise_quote",
  "pricing_details": "Reported non-reimbursed per-use price ~53,000 KRW (public media); commercial licensing and deployment fees — contact vendor for current pricing and trial options.",
  "license": "commercial proprietary",
  "deployment_model": [
    "cloud-based",
    "hybrid",
    "on-prem (dedicated hardware)"
  ],
  "os_platforms": [
    "Web",
    "Windows"
  ],
  "features": [
    "Ischemic stroke lesion detection (MRI)",
    "Ischemic stroke subtype classification (TOAST)",
    "Multi-sequence MRI analysis (DWI required; FLAIR, T1, T2 supported)",
    "Probability scores for stroke subtypes",
    "Heatmap overlay visualization on images",
    "DICOM and JPEG image input",
    "Fast processing (reported 3–10 seconds)",
    "On-demand image upload / user-triggered analysis",
    "Stand-alone and web-based operation modes",
    "Integration as third-party application or web service"
  ],
  "optional_modules": [],
  "integrations": [],
  "data_standards": [
    "DICOM"
  ],
  "api_available": "unknown",
  "system_requirements": "DICOM-compatible image input; runs cloud, hybrid, or on dedicated local hardware",
  "compliance": [
    "CE (MDD)"
  ],
  "certifications": [
    "CE (MDD)",
    "MFDS (Korea)"
  ],
  "security_features": [],
  "privacy_features": [],
  "data_residency": "",
  "customers": [
    "Korea University Medical Center",
    "Kyungpook National University Hospital",
    "Seoul National University Hospital",
    "Bundang Seoul National University Hospital",
    "Seoul National University Hospital Gangnam Center",
    "Korea Veterans Health Service (HVMC)",
    "Catholic University Seoul St. Mary's Hospital",
    "Incheon St. Mary's Hospital",
    "Chung-Ang University Hospital",
    "Severance Hospital (Yonsei University)",
    "Jeonnam National University Hospital",
    "Samsung Medical Center",
    "Asan Medical Center",
    "Dongguk University Ilsan Hospital",
    "Gachon Gil Medical Center",
    "University of Missouri Health Care",
    "Clinton Foundation"
  ],
  "user_reviews": [],
  "ratings": [
    "CE mark (MDD) — listed as CE certified on Health AI Register",
    "Approved by South Korea Ministry of Food and Drug Safety (MFDS) as AI-based Class III device (JLK PR Newswire)"
  ],
  "support_channels": [
    "email",
    "phone",
    "onsite"
  ],
  "training_options": [
    "documentation",
    "webinars",
    "live_online",
    "onsite"
  ],
  "release_year": "2019",
  "integration_partners": [
    "Intel",
    "Intel OpenVINO",
    "MEDICOM",
    "Medikind",
    "IGM7",
    "University of Missouri Health Care",
    "Clinton Foundation",
    "CETI",
    "TBFree"
  ],
  "id": "P2085",
  "slug": "jbs-01k",
  "type": "product",
  "version": "1.0",
  "last_updated": "2025-09-07",
  "links_json": {
    "self": "https://www.healthaidb.com/software/jbs-01k.json"
  }
}